Skip to content

Peer Mentored Approaches For Men And Women With Coronary Artery Disease (4Steps)

Peer Mentored Approaches For Men And Women With Coronary Artery Disease (4Steps)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03020316
Enrollment
72
Registered
2017-01-13
Start date
2016-04-30
Completion date
2019-11-22
Last updated
2019-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

This study will be a pilot prospective randomized study using a peer mentor with or without Transcendental Meditation as compared to usual care for men and women with a new diagnosis of coronary artery disease (CAD). The study is designed to explore between cohort comparisons of perceived stress and a number of additional outcomes. The results of this pilot study will be used in the design of larger future trials. The target population is adult men and women with a new diagnosis of CAD made on the basis of a myocardial infarction, coronary revascularization procedure, acute coronary syndrome, or imaging test suggestive of CAD. The overall hypothesis of this proposal is that the addition of a peer mentor and training in Transcendental Meditation to usual care will improve perceived stress and medication adherence for men and women with newly diagnosed CAD as compared with usual care.

Detailed description

The overall hypothesis of this proposal is that the addition of a peer mentor and training in Transcendental Meditation to usual care will improve perceived stress and medication adherence for men and women with newly diagnosed CAD as compared with usual care. Participants will be randomized into one of two study groups: Arm 1 - Standard Of Care (SOC) Arm 3 - SOC, assignment of a peer mentor, and the opportunity to receive training in transcendental meditation We are no longer enrolling in Arm 2 of the study (SOC and subjects addition of a peer mentor). Subjects will be assessed at baseline, 1 month, 6 months, and 12 months with surveys and assessments. SOC may include routine outpatient physician assessment, preventive medications with appropriate titration, routine blood draws, advice on lifestyle change, referral to cardiac rehabilitation, use of commercially available medical apps. Investigation - use of peer mentor and use of transcendental meditation. 1. Peer mentor: These are volunteers with CAD, who will undergo training prior to be assigned a mentee. Content of the training will focus on a review of health counseling, basics of CAD pathophysiology and medications, information on situations where the mentor should advise the subject to contact her doctor, and confidentiality. Mentors are intended to provide psychosocial and limited educational support for subjects. 2. Transcendental meditation (TM). TM is a standardized meditation technique done 20 minutes twice each day while sitting with the eyes closed. Although data are heterogeneous, TM has been demonstrated to reduce blood pressure in several small studies.

Interventions

BEHAVIORALPeer Mentor

A volunteer with a similar disease as the subject

A meditation technique

Sponsors

Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

For Participants: * Men and women aged 18-90 * English speaking * Newly diagnosed with CAD (myocardial infarction \[MI\], percutaneous coronary intervention \[PCI\], coronary artery bypass graft \[CABG\]), acute coronary syndrome, or any imaging test suggestive of CAD). For Mentors: (Male mentors will be paired with male participants, and female mentors will be paired with female participants.) * Men and women aged 18-90 * English speaking * Established (greater than 1yr prior to study) diagnosis of CAD (myocardial infarction \[MI\], percutaneous coronary intervention \[PCI\], coronary artery bypass graft \[CABG\] acute coronary syndrome, or imaging test suggestive of CAD).

Exclusion criteria

For Participants: * Previously diagnosed CAD (MI, PCI, CABG, acute coronary syndrome or imaging test suggestive of CAD) * Inability or unwillingness to provide written consent * Non-English speaking * Prior formal training and practice of TM For Mentors: * Inability or unwillingness to provide written consent * Non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
Perceived Stress52 weeksCohen Perceived Stress Scale (PSS-10) Each item is rated on a 5-point scale ranging from never (0) to almost always (4). Positively worded items are reverse scored, and the ratings are summed, with higher scores indicating more perceived stress. Total scale range: 0-40. Scores around 13 are considered average. Scores of 20 or higher are considered high stress.

Secondary

MeasureTime frameDescription
Hospital readmission52 weeksWas the subject readmitted or not
Height52 weeksHeight (m)
Weight52 weeksWeight (kg)
Blood pressure52 weeksBlood pressure (mmHg)
Heart rate52 weeksHeart rate (beats/min)
Waist circumference52 weeksWaist circumference (cm)
Lipid panel results52 weeksTotal cholesterol, LDL, HDL, triglycerides (mg/dL)
Fasting plasma glucose52 weeksFasting plasma glucose levels (mg/dL)
Medication Adherence (VAS)52 weeksVisual analog scale for medication adherence Total scale range: 0-100%. Higher percentage indicates better adherence.
Depressive Symptoms52 weeksCenter for Epidemiologic Studies Depression Scale (CES-D) Total scale range: 0-60. Total score of 16 or higher is considered depressed.
Changes in physical activity52 weeksMeasured by International Physical Activity Questionnaire (IPAQ) Survey does not include a range of possible values. Based on verbal description of activity and participation time, populations are divided into 3 proposed levels of physical activity: inactive, minimally active, and HEPA active.
Number and manner of contacts between participants and mentors52 weeksVerbal description
Participant feedback about mentorship and TM52 weeksVerbal description
Participant knowledge about CAD52 weeksVerbal description
Medication Adherence (ARMS-7)52 weeksAdherence to Refills and Medication Scale (ARMS-7) Total scale range: 7-28; subscale range: 1-4. Scores can be treated as a continuous measure or dichotomized as 7 or \>7. Lower scores indicate better adherence.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026